New Antiarrhythmic Drug for the Treatment of Atrial Fibrillation. Study Data, Clinical Guidelines, Regulatory Agency Recommendations

Rational Pharmacotherapy in Cardiology - Russian Federation
doi 10.20996/1819-6446-2011-7-6-770-774
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Related search

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Adherence to Guideline Recommendations for Antiarrhythmic Drugs in Atrial Fibrillation

American Heart Journal
Cardiovascular MedicineCardiology
2013English

New Atrial Fibrillation Guidelines

Pharmacy Today
2015English

Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients With Left Ventricular Dysfunction

Japanese Journal of Electrocardiology
2014English

The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2015English

Managing Atrial Fibrillation: Catheter Ablation or Antiarrhythmic Therapy?

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2009English

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation

JAMA - Journal of the American Medical Association
Medicine
2005English

New System for Detecting Drug Side Effects Can Beat Regulatory Agency

BMJ
2007English

Dronedarone for the Treatment of Atrial Fibrillation and Atrial Flutter

Health Technology Assessment
MedicineHealth Policy
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy